Results 41 to 50 of about 30,754 (261)

Interventional Mitral Valve Edge‐to‐Edge Repair in Patients Above 85 Years of Age

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Mitral valve transcatheter‐edge‐to‐edge repair (M‐TEER) is routinely performed in patients with severe mitral regurgitation (MR) at high operative risk, frequently including elderly patients. Patients ≥ 85 years, however, are frequently excluded in clinical studies.
Florian Jürgens, Florian Schindhelm, Mohammed Abusharekh, Jürgen Kampf, Matthias Totzeck, Fadi Al‐Rashid, Peter Lüdike, Tienush Rassaf, Amir A. Mahabadi   +8 more
wiley   +1 more source

Sex differences in the association between nutritional status and in‐hospital mortality in HFpEF patients [PDF]

Aims: The study aimed to assess whether the effect of nutritional risk score (NRS‐2002) on the odds of in‐hospital mortality would be modulated by sex and body mass index (BMI) in patients with heart failure with preserved ejection fraction (HFpEF ...
Uchmanowicz, Izabella, Grajeta, Halina, Czapla, Michał, Lee, Christopher S., Czapla, Michał [0000-0002-4245-5420], Pietrzykowski, Łukasz, Lewandowski, Łukasz, Kosowski, Wojciech, Kwaśny, Adrian, Surma, Stanisław   +9 more
core   +1 more source

Do we need a definition of acute heart failure with preserved ejection fraction?

Annals of Medicine, 2021
Heart failure with preserved ejection fraction (HFpEF) might soon become the most prevalent type of acute heart failure. Still, despite more than 30 years of research on HFpEF, not only do we lack specific treatment, but also a generally accepted ...
Agnieszka Kapłon-Cieślicka, Lars H. Lund   +1 more
doaj   +1 more source

Smartphone, Mom, and HFpEF

JACC: Heart Failure, 2018
![Figure][1] I had the wonderful opportunity to spend time with my mom over the holidays. For her 88th birthday 6 months ago, we presented her with a smartphone, a new challenging technology that she was reluctant to adopt given that she had a flip phone for over a decade.
openaire   +2 more sources

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source

Heart failure with preserved ejection fraction in middle-aged women and history of adverse pregnancy outcomes

Рациональная фармакотерапия в кардиологии
Aim. To determine the associations between adverse pregnancy outcomes (APOs) and the presence of heart failure with preserved ejection fraction (HFpEF) in middleaged women.Material and methods. The study included 102 women aged 45-59 years with a history
M. I. Shperling, V. M. Kosulina, Yu. S. Timofeev, N. V. Lyubimova, I. A. Klimanov, O. N. Dzhioeva, O. M. Drapkina   +6 more
doaj   +1 more source

Heart failure with preserved ejection fraction: A short review of diagnosis and management [PDF]

КардиоСоматика
Around 64 million persons in the world have heart failure (HF). HF patients with left ventricle ejection fraction (LVEF) of ≥50% are classified as having HF with preserved ejection fraction (HFpEF).
Sidhi Laksono, Prita Saskya Prameswari
doaj   +1 more source

Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction

Frontiers in Cardiovascular Medicine, 2023
BackgroundBoth secondary tricuspid regurgitation (STR) and heart failure with preserved ejection fraction (HFpEF) are relevant public health problems in the elderly population, presenting with potential overlaps and sharing similar risk factors. However,
Claudia Baratto, Sergio Caravita, Sergio Caravita, Giorgia Corbetta, Giorgia Corbetta, Davide Soranna, Antonella Zambon, Antonella Zambon, Céline Dewachter, Mara Gavazzoni, Francesca Heilbron, Michele Tomaselli, Noela Radu, Francesco Paolo Perelli, Francesco Paolo Perelli, Giovanni Battista Perego, Jean-Luc Vachiéry, Gianfranco Parati, Gianfranco Parati, Luigi P. Badano, Luigi P. Badano, Denisa Muraru, Denisa Muraru   +22 more
doaj   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities

, 2020
Heart failure with preserved ejection fraction (HFpEF) is a complex heterogeneous disease for which our pathophysiological understanding is still limited and specifc prevention and treatment strategies are lacking.
Kuhn, A.R. (Annika R.), Simmonds, S. (Steven J.), Heymans, S. (Stephane), Czarnowska, E. (Elzbieta), Brakenhielm, E. (Ebba), Bilsen, M. (Marc) van, González-Miqueo, A. (Aránzazu), Cuijpers, I. (Ilona), Mulder, P. (Paul), Jones, E.A.V. (Elizabeth A. V.), Ratajska, A. (Anna)   +10 more
core   +1 more source